Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Colombo, G.
Right arrow Articles by Gessa, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colombo, G.
Right arrow Articles by Gessa, G. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Alcohol and Alcoholism Vol. 37, No. 5, pp. 499-503, 2002
© 2002 Medical Council on Alcohol


PROCEEDINGS OF A SYMPOSIUM ENTITLED: 'GABAB RECEPTORS: A TARGET OF NEW TREATMENTS FOR ALCOHOLISM AND DRUG ABUSE'

THE GABAB RECEPTOR AGONISTS BACLOFEN AND CGP 44532 PREVENT ACQUISITION OF ALCOHOL DRINKING BEHAVIOUR IN ALCOHOL-PREFERRING RATS

Giancarlo Colombo1,*, Salvatore Serra1,2, Giuliana Brunetti1,2, Giuliana Atzori2, Marialaura Pani2, Giovanni Vacca1,2, Giovanni Addolorato3, Wolfgang Froestl4, Mauro A. M. Carai2 and Gian Luigi Gessa1,2,5

1 C.N.R. Institute of Neurogenetics and Neuropharmacology, Cagliari,
2 Neuroscienze S.c.a r.l., Cagliari,
3 Institute of Internal Medicine, Catholic University of Rome, Rome, Italy,
4 Research Department, Novartis Pharma AG, Basel, Switzerland and
5 ‘Bernard B. Brodie’ Department of Neuroscience, University of Cagliari, Cagliari, Italy

Received 23 January 2002; first review notified 26 March 2002; accepted 27 March 2002

ABSTRACT

Aims: The present study investigated the effect of the {gamma}-aminobutyric acid (GABA)B receptor agonists, baclofen and CGP 44532, on the acquisition of alcohol drinking behaviour in selectively bred Sardinian alcohol-preferring (sP) rats. Methods: Baclofen [0, 1 and 3 mg/kg, intraperitoneally (i.p.)] and CGP 44532 (0, 0.1, 0.3 and 1 mg/kg, i.p.) were administered immediately before alcohol presentation to alcohol-naive sP rats. Alcohol was offered under the two-bottle free-choice regimen with unlimited access for 24 h/day. Drug treatment was repeated once daily for 10 consecutive days. Results: Baclofen and CGP 44532, dose-dependently and with comparable efficacy, suppressed alcohol intake; compensatory increases in water intake left total fluid intakes virtually unchanged. Conclusions: These results demonstrate that baclofen and CGP 44532 prevent the acquisition of alcohol drinking behaviour in sP rats, and suggest the involvement of the GABAB receptor in the mechanisms underlying the disclosure and experience of the reinforcing properties of alcohol in this rat line.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Alcohol AlcoholHome page
G. L. GESSA, S. SERRA, G. VACCA, M. A. M. CARAI, and G. COLOMBO
SUPPRESSING EFFECT OF THE CANNABINOID CB1 RECEPTOR ANTAGONIST, SR147778, ON ALCOHOL INTAKE AND MOTIVATIONAL PROPERTIES OF ALCOHOL IN ALCOHOL-PREFERRING sP RATS
Alcohol Alcohol., January 1, 2005; 40(1): 46 - 53.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
G. Addolorato, F. Caputo, E. Capristo, M. Domenicali, M. Bernardi, L. Janiri, R. Agabio, G. Colombo, G. L. Gessa, and G. Gasbarrini
BACLOFEN EFFICACY IN REDUCING ALCOHOL CRAVING AND INTAKE: A PRELIMINARY DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY
Alcohol Alcohol., September 1, 2002; 37(5): 504 - 508.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.